Taha Ould Rouis

Taha Ould Rouis, MD, is a seasoned professional in clinical development with extensive experience across various therapeutic areas, including rare genetic diseases, oncology, and cystic fibrosis. Currently serving as Associate Director of Clinical Development at Alexion Pharmaceuticals, Inc., since July 2024, Taha's previous roles include Associate Director at Amolyt Pharma and Hays Pharma, overseeing clinical operations and medical affairs for notable companies. Taha began a clinical career at Hôpital Necker-Enfants Malades and Hôpital de la Pitié-Salpetrière as a Junior Doctor. Taha earned a Medical Doctor degree from the Faculty of Medicine in Algiers.